Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Bongarzoni, A."'
Autor:
Gino Palone, Aldo Bove, Raffaella Di Renzo, Giuseppe Bongarzoni, Marco Ricciardiello, Paolo Panaccio, Sara Ciuffreda
Publikováno v:
Gastroenterology Report
BackgroundWe utilized transcystic clearance and intra-operative papillotomy through a rendezvous technique for the treatment of cholecysto-choledocolithiasis. The goal of this study was to evaluate the reliability of pre-operative parameters to addre
Autor:
Velia Bongarzoni, Dimitar G. Efremov, Robin Foà, Giovanni Del Poeta, Roberta Murru, Stefania Ciolli, Maria Rosa Lanza Cariccio, Francesca Romana Mauro, Maria Ilaria Del Principe, Riccardo Boncompagni, Maria Cantonetti, Agostino Cortelezzi, Giovanni D'Arena, Idanna Innocenti, Francesco Ghio, Patrizia Mondello, Simona Sica, Vincenzo Pitini, Barbara Vannata, Nicola Piccirillo, Giulia Cervetti, Francesco Autore, Gianluigi Reda, Paola Anticoli Borza, Luca Laurenti, Alessandro Gozzetti
Publikováno v:
Leukemia Research. 39:1066-1070
The front-line therapy for CLL young and fit patients is chemo-immunotherapy with fludarabine-cyclophosphamide-rituximab (FCR). FCR regimen results in a significant myelosuppression and high rates of early and late infections especially in elderly pa
Autor:
Aldo Bove, Raffaella Di Renzo, Lucia Marino, Alessandro Bennato, Giuseppe Bongarzoni, Gino Palone
Publikováno v:
American Journal of Gastroenterology. 112:S1451-S1452
Autor:
Maurizio Musso, Nicola Di Renzo, Fortunato Morabito, Antonino Mulè, Emilio Iannitto, Andrea Piccin, Giovanni Franco, Elsa Pennese, Massimo Gentile, Giuseppe Visani, Salvatrice Mancuso, Roberto Marasca, Luigi Rigacci, Rita Fazzi, Pellegrino Musto, Velia Bongarzoni, Alfonso Maria D'Arco, A Augello, Delia Rota-Scalabrini, Antonella Montanini
Publikováno v:
British Journal of Haematology. 153:351-357
To retrospectively assess the efficacy of bendamustine alone and with rituximab (R-B), 109 patients with relapsed chronic lymphocytic leukaemia (CLL) were enrolled in 24 Italian centres. The median age was 66 years (range 39-85). Forty-three percent
Autor:
Giuseppe Bongarzoni, Vincenzo D'Addetta, R.M. Di Renzo, S. Chiarini, C. Antonopulos, Gino Palone, Paolo Panaccio, Aldo Bove, F. Caldararo
Publikováno v:
International journal of surgery (London, England). 12
Patients with symptomatic gallstones present common bile duct stones in approximately 10% of cases. It is possible to resolve both gallbladder and bile duct stones with a single procedure. The aim of this study is to determine the effectiveness of a
Autor:
Manuela Bellobono, Giuseppe Bongarzoni, Aldo Bove, Raffaella Di Renzo, Gauro Dʼurbano, Gino Palone, Vincenzo DʼAddetta
Publikováno v:
American Journal of Gastroenterology. 111:S1287
Autor:
Silvia Betti, Stefano Felici, Elisabetta Calabrese, Maria Teresa Petrucci, Velia Bongarzoni, Francesco Pisani, Fabiana Gentilini, Elena Rossi, Angela Maria Ciminello, Fabio Torelli, Luciana Annino, Giuseppe Leone, Valerio De Stefano, Tommaso Caravita, Angela Rago, Alessandro Andriani, Tommaso Za, Nicoletta Villivà, Giuseppe Cimino, Anna Levi
Monoclonal gammopathy of undetermined significance (MGUS) has been associated with an increased risk of thrombosis. We carried out a retrospective multicentre cohort study on 1491 patients with MGUS. In 49 patients (3.3%) MGUS was diagnosed after a t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a92adec3ea8112a7828190159ee878e9
http://hdl.handle.net/11573/557501
http://hdl.handle.net/11573/557501
Autor:
Velia Bongarzoni, Alessandro Andriani, Giovanni D'Arena, Enrico Balleari, Maria Teresa Petrucci, Sara Bringhen, Mario Boccadoro, Pellegrino Musto, Tommaso Caravita, Antonio Palumbo, Tommasina Guglielmelli, Giuseppe Pietrantuono
Publikováno v:
Cancer. 113(7)
BACKGROUND. Bisphosphonates (BPs) are effective in the prevention and treatment of skeletal-related events (SREs) in patients with symptomatic myeloma who are receiving chemotherapy. Recent data also suggest a possible antineoplastic activity of BPs.
Autor:
Andrea Camera, Giulio Giordano, Gianluca Gaidano, Eustachio Miraglia, Davide Rossi, Luciana Annino, Francesco Di Raimondo, Sergio Storti, Giovanni Martinelli, Maide Cavalli, Velia Bongarzoni, Alfredo Gagliardi
Meningeal blastic involvement is a severe complication of aggressive non-Hodgkin lymphoma (NHL) and acute leukemia (AL). DepoCyte® is an unique liposomal formulation for IT administration, that provides a lower toxicity profile and a more convenient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70b327a24ff77d25f86a8048869d5ee8
http://hdl.handle.net/20.500.11769/76661
http://hdl.handle.net/20.500.11769/76661
Autor:
Alessandro Gozzetti, Francesca Romana Mauro, Velia Bongarzoni, Mariarita Sciumè, Robin Foà, Francesco Ghio, Patrizia Mondello, Giovanni Del Poeta, Anticoli Borza Paola, Riccardo Boncompagni, Mario Petrini, Nicola Piccirillo, Maria Rosa Lanza Cariccio, Daniele Vincenti, Giovanni D'Arena, Roberta Murru, Agostino Cortelezzi, Vincenzo Pitini, Maria Ilaria Del Principe, Barbara Vannata, Simona Sica, Nadia Cecconi, Luca Laurenti, Stefania Ciolli, F. Autore, Idanna Innocenti, Maria Cantonetti
Publikováno v:
Blood. 124:5655-5655
The front-line therapy for CLL young and fit patients is chemo-immunotherapy with Fludarabine-Cyclophosphamide and Rituximab (FCR). However, around three quarter of the patients with a newly diagnosed CLL are 65 years or older, with approximately 42%